These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9068810)

  • 1. Immunotherapy: a new strategy for tuberculosis control?
    Grange JM
    Respir Med; 1997 Jan; 91(1):1-4. PubMed ID: 9068810
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of vaccines in a murine model of dormant tuberculosis.
    Dhillon J; Mitchison DA
    Tuber Lung Dis; 1994 Feb; 75(1):61-4. PubMed ID: 8161768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunotherapy in tuberculosis].
    Demkow U; Chorostowska-Wynimko J
    Pneumonol Alergol Pol; 1997; 65(3-4):278-82. PubMed ID: 9489427
    [No Abstract]   [Full Text] [Related]  

  • 4. A modern approach to the immunotherapy of tuberculosis.
    Stanford JL; Bahr GM; Byass P; Corrah T; Dowlati Y; Lucas S; Shaaban M; Torres P
    Bull Int Union Tuberc Lung Dis; 1990; 65(2-3):27-9. PubMed ID: 2257350
    [No Abstract]   [Full Text] [Related]  

  • 5. The promise of immunotherapy for tuberculosis.
    Stanford JL; Grange JM
    Respir Med; 1994 Jan; 88(1):3-7. PubMed ID: 8029511
    [No Abstract]   [Full Text] [Related]  

  • 6. Mycobacterium w immunotherapy in leprosy.
    Whitty C
    Lepr Rev; 1998 Sep; 69(3):222-4. PubMed ID: 9805877
    [No Abstract]   [Full Text] [Related]  

  • 7. Trial of BCG vaccines in south India for tuberculosis prevention. 1979.
    Tuberculosis Prevention Trial
    Indian J Med Res; 2013 Mar; 137(3):571. PubMed ID: 23776969
    [No Abstract]   [Full Text] [Related]  

  • 8. Modern vaccines. Mycobacterial diseases.
    Fine PE; Rodrigues LC
    Lancet; 1990 Apr; 335(8696):1016-20. PubMed ID: 1970071
    [No Abstract]   [Full Text] [Related]  

  • 9. The BCG replacement vaccine VPM1002: from drawing board to clinical trial.
    Kaufmann SH; Cotton MF; Eisele B; Gengenbacher M; Grode L; Hesseling AC; Walzl G
    Expert Rev Vaccines; 2014 May; 13(5):619-30. PubMed ID: 24702486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy and immunoprophylaxis of leprosy.
    Convit J; Ulrich M
    Indian J Lepr; 2000; 72(1):21-32. PubMed ID: 10935184
    [No Abstract]   [Full Text] [Related]  

  • 11. A case for a neonatal, low-dose BCG vaccination trial.
    Bretscher P; Menon J; Power C; Uzonna J; Wei G
    Scand J Infect Dis; 2001; 33(4):253-7. PubMed ID: 11345215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy of tuberculosis with Mycobacterium vaccae NCTC 11659.
    Stanford JL; Stanford CA
    Immunobiology; 1994 Oct; 191(4-5):555-63. PubMed ID: 7713570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The BCG controversy. A methodological and statistical reappraisal.
    Clemens JD; Chuong JJ; Feinstein AR
    JAMA; 1983 May; 249(17):2362-9. PubMed ID: 6834635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel TB vaccine; towards a strategy based on our understanding of BCG failure.
    Agger EM; Andersen P
    Vaccine; 2002 Nov; 21(1-2):7-14. PubMed ID: 12443657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium vaccae immunotherapy for treating tuberculosis.
    de B; Garner P
    Cochrane Database Syst Rev; 2001; (1):CD001166. PubMed ID: 11279709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospects in Mycobacterium bovis Bacille Calmette et Guérin (BCG) vaccine diversity and delivery: why does BCG fail to protect against tuberculosis?
    Moliva JI; Turner J; Torrelles JB
    Vaccine; 2015 Sep; 33(39):5035-41. PubMed ID: 26319069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel human in vitro system for evaluating antimycobacterial vaccines.
    Kampmann B; Tena GN; Mzazi S; Eley B; Young DB; Levin M
    Infect Immun; 2004 Nov; 72(11):6401-7. PubMed ID: 15501770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [BCG vaccine therapy associated with INH chemotherapy in experimental tuberculosis].
    NASTA M; ARHIRI M; ALGEORGE G
    Rev Sci Med; 1962; 7():79-81. PubMed ID: 13937643
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.